Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation.

Abstract

Authors

• Jiajun Li
  School of Management, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, China.
• Nuo Xu
  Information Engineering, Guangdong University of Technology, Guangzhou, China.
• Leyin Hu
  Department of Pathology, Zhejiang Cancer Hospital, Hangzhou, 305000, Zhejiang, China.
• Jiayue Xu
  Burning Rock Biotech, Guangzhou, China.
• Yifan Huang
  Department of Orthopedics, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
• Deqi Wang
  Department of Gastroenterology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
• Feng Chen
  Department of Integrated Care Management Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
• Yi Wang
  Department of Neurology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.
• Jiani Jiang
  Department of Gastroenterology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China.
• Yanggang Hong
  The Second School of Clinical Medicine, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China. sun160414@icloud.com.
• Huajun Ye
  Department of Gastroenterology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, 325000, Zhejiang, China. yehuajun2020@163.com.

Keywords

External Resources